FMC Corporation Reports Q1 2026 Financial Results with Significant Losses
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy FMC?
Source: Newsfilter
- Revenue Decline: FMC reported Q1 2026 revenue of $759 million, down 4% year-over-year, with revenue excluding India at $762 million, indicating ongoing challenges in global markets, particularly due to a 5% sales headwind from the divestiture of the Indian business.
- Widening Net Loss: The company recorded a GAAP net loss of $281 million in Q1, an increase of $266 million compared to Q1 2025, primarily driven by lower sales, higher restructuring costs, and increased interest expenses, reflecting difficulties in cost control and market competition.
- Significant EBITDA Drop: Adjusted EBITDA for Q1 was $72 million, a 40% decline year-over-year, indicating a substantial weakening in profitability under pressure from pricing and unfavorable costs, necessitating more effective cost management strategies to restore profitability.
- 2026 Outlook Maintained: FMC reaffirmed its 2026 revenue guidance of $3.60 billion to $3.80 billion, expecting a 5% decline year-over-year, while adjusted EBITDA is projected at $670 million to $730 million, demonstrating a cautious approach amid market challenges, although new active ingredient sales are expected to grow over 75%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FMC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FMC
Wall Street analysts forecast FMC stock price to rise
14 Analyst Rating
3 Buy
10 Hold
1 Sell
Hold
Current: 15.260
Low
13.00
Averages
19.08
High
28.00
Current: 15.260
Low
13.00
Averages
19.08
High
28.00
About FMC
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
FMC Reports Q1 2026 Earnings with Mixed Results
- Earnings Beat: FMC's Q1 non-GAAP EPS of $0.23 exceeded expectations by $0.61, indicating resilience in profitability despite a 4.1% year-over-year revenue decline.
- Revenue and Loss: The company reported revenue of $759 million, beating estimates by $16.59 million, yet faced a GAAP net loss of $281 million, a decline of $266 million compared to Q1 2025, highlighting ongoing challenges.
- Adjusted EBITDA Decline: Adjusted EBITDA fell to $72 million, down 40% year-over-year, suggesting a need for improved cost control and operational efficiency to navigate market pressures.
- 2026 Outlook Maintained: FMC maintains its full-year 2026 outlook with projected revenue between $3.60 billion and $3.80 billion, reflecting a cautious stance as it anticipates a 5% decline at the midpoint compared to 2025.
See More
FMC Corporation Reports Q1 2026 Financial Results and Strategic Outlook
- Revenue Decline: FMC Corporation reported Q1 2026 revenue of $759 million, a 4% decrease year-over-year, with revenue excluding India at $762 million, indicating significant challenges in the global market, particularly due to a 5% sales headwind from the divestiture of its India business.
- Widening Loss Per Share: The company reported a diluted loss per share of $2.25 for Q1, an increase of $2.13 compared to the same period in 2025, reflecting pressures from restructuring costs and higher interest expenses that have worsened its overall financial condition.
- Significant EBITDA Drop: Adjusted EBITDA for the first quarter was $72 million, down 40% year-over-year, primarily driven by declining prices and unfavorable cost impacts, highlighting the company's struggles in a competitive market environment.
- Strategic Options Evaluation: FMC is actively evaluating multiple strategic alternatives to improve its financial health, aiming to strengthen its balance sheet through targeted debt reduction of approximately $1 billion while driving growth in new active ingredient sales to address future market challenges.
See More
FMC Corporation Reports Q1 2026 Financial Results with Significant Losses
- Revenue Decline: FMC reported Q1 2026 revenue of $759 million, down 4% year-over-year, with revenue excluding India at $762 million, indicating ongoing challenges in global markets, particularly due to a 5% sales headwind from the divestiture of the Indian business.
- Widening Net Loss: The company recorded a GAAP net loss of $281 million in Q1, an increase of $266 million compared to Q1 2025, primarily driven by lower sales, higher restructuring costs, and increased interest expenses, reflecting difficulties in cost control and market competition.
- Significant EBITDA Drop: Adjusted EBITDA for Q1 was $72 million, a 40% decline year-over-year, indicating a substantial weakening in profitability under pressure from pricing and unfavorable costs, necessitating more effective cost management strategies to restore profitability.
- 2026 Outlook Maintained: FMC reaffirmed its 2026 revenue guidance of $3.60 billion to $3.80 billion, expecting a 5% decline year-over-year, while adjusted EBITDA is projected at $670 million to $730 million, demonstrating a cautious approach amid market challenges, although new active ingredient sales are expected to grow over 75%.
See More
FMC Corporation Declares Quarterly Dividend of 8 Cents
- Quarterly Dividend Announcement: FMC Corporation's board of directors has declared a quarterly dividend of 8 cents per share, payable on July 16, 2026, to shareholders of record as of June 30, 2026, indicating the company's ongoing commitment to shareholder returns.
- Shareholder Return Strategy: This dividend payment reflects FMC's confidence in its stable cash flow and profitability, aimed at enhancing investor trust while providing funding support for future investments and expansions.
- Company Background: FMC is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber, and fuel in a changing environment, with innovative crop protection solutions that include biologicals, crop nutrition, and digital agriculture to address agricultural challenges economically.
- Forward-Looking Statements: The announcement includes caution regarding forward-looking statements, highlighting that future performance and market conditions may be influenced by various risks and uncertainties, advising investors to be cautious in relying on such statements.
See More
FMC Corporation Q1 Earnings Announcement Scheduled
- Earnings Release Date: FMC Corporation is set to announce its Q1 earnings on April 29th after market close, with consensus EPS estimate at -$0.38 and revenue forecast at $742.41 million, reflecting a 6.2% year-over-year decline, indicating challenges in the current economic environment.
- Historical Performance Review: Over the past two years, FMC has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating a degree of stability in financial performance, although recent estimate revisions indicate downward pressure.
- Estimate Revision Trends: In the last three months, there have been no upward revisions for EPS estimates and 11 downward revisions, while revenue estimates also saw no upward revisions and 7 downward adjustments, suggesting weakened market confidence in FMC's future performance, which may affect investor sentiment.
- Market Dynamics: Despite facing challenges, FMC's recent approval for the Isoflex herbicide active ingredient in the EU may support future product line expansion and enhance market competitiveness, showcasing its ongoing innovation capabilities in the agricultural chemicals sector.
See More
Old North State Fully Divests FMC Stake Amid Losses
- Complete Exit from FMC: Old North State Wealth Management sold its entire stake of 295,829 shares in FMC Corporation during Q1 2026, with an estimated transaction value of approximately $4.42 million, indicating a significant loss of confidence in FMC's future prospects.
- Significant Price Decline: As of April 16, 2026, FMC shares were priced at $17.58, reflecting a 50% drop over the past year, which starkly contrasts with the S&P 500's roughly 35% gain during the same period, highlighting the challenging market conditions faced by the company.
- Deteriorating Financials: FMC's annual revenue has declined by 18% to around $3.47 billion, resulting in a net loss of $2.24 billion primarily due to impairments and restructuring efforts, with management projecting further revenue declines for 2026 between $3.6 billion and $3.8 billion.
- Strategic Alternatives Considered: The company is exploring strategic alternatives, including a potential sale, while aiming to reduce $1 billion in debt through asset disposals, indicating proactive measures to improve its financial situation amidst ongoing challenges.
See More
FMC Reports Q1 2026 Earnings with Mixed Results
- Earnings Beat: FMC's Q1 non-GAAP EPS of $0.23 exceeded expectations by $0.61, indicating resilience in profitability despite a 4.1% year-over-year revenue decline.
- Revenue and Loss: The company reported revenue of $759 million, beating estimates by $16.59 million, yet faced a GAAP net loss of $281 million, a decline of $266 million compared to Q1 2025, highlighting ongoing challenges.
- Adjusted EBITDA Decline: Adjusted EBITDA fell to $72 million, down 40% year-over-year, suggesting a need for improved cost control and operational efficiency to navigate market pressures.
- 2026 Outlook Maintained: FMC maintains its full-year 2026 outlook with projected revenue between $3.60 billion and $3.80 billion, reflecting a cautious stance as it anticipates a 5% decline at the midpoint compared to 2025.
See More
FMC Corporation Reports Q1 2026 Financial Results and Strategic Outlook
- Revenue Decline: FMC Corporation reported Q1 2026 revenue of $759 million, a 4% decrease year-over-year, with revenue excluding India at $762 million, indicating significant challenges in the global market, particularly due to a 5% sales headwind from the divestiture of its India business.
- Widening Loss Per Share: The company reported a diluted loss per share of $2.25 for Q1, an increase of $2.13 compared to the same period in 2025, reflecting pressures from restructuring costs and higher interest expenses that have worsened its overall financial condition.
- Significant EBITDA Drop: Adjusted EBITDA for the first quarter was $72 million, down 40% year-over-year, primarily driven by declining prices and unfavorable cost impacts, highlighting the company's struggles in a competitive market environment.
- Strategic Options Evaluation: FMC is actively evaluating multiple strategic alternatives to improve its financial health, aiming to strengthen its balance sheet through targeted debt reduction of approximately $1 billion while driving growth in new active ingredient sales to address future market challenges.
See More
FMC Corporation Reports Q1 2026 Financial Results with Significant Losses
- Revenue Decline: FMC reported Q1 2026 revenue of $759 million, down 4% year-over-year, with revenue excluding India at $762 million, indicating ongoing challenges in global markets, particularly due to a 5% sales headwind from the divestiture of the Indian business.
- Widening Net Loss: The company recorded a GAAP net loss of $281 million in Q1, an increase of $266 million compared to Q1 2025, primarily driven by lower sales, higher restructuring costs, and increased interest expenses, reflecting difficulties in cost control and market competition.
- Significant EBITDA Drop: Adjusted EBITDA for Q1 was $72 million, a 40% decline year-over-year, indicating a substantial weakening in profitability under pressure from pricing and unfavorable costs, necessitating more effective cost management strategies to restore profitability.
- 2026 Outlook Maintained: FMC reaffirmed its 2026 revenue guidance of $3.60 billion to $3.80 billion, expecting a 5% decline year-over-year, while adjusted EBITDA is projected at $670 million to $730 million, demonstrating a cautious approach amid market challenges, although new active ingredient sales are expected to grow over 75%.
See More
FMC Corporation Declares Quarterly Dividend of 8 Cents
- Quarterly Dividend Announcement: FMC Corporation's board of directors has declared a quarterly dividend of 8 cents per share, payable on July 16, 2026, to shareholders of record as of June 30, 2026, indicating the company's ongoing commitment to shareholder returns.
- Shareholder Return Strategy: This dividend payment reflects FMC's confidence in its stable cash flow and profitability, aimed at enhancing investor trust while providing funding support for future investments and expansions.
- Company Background: FMC is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber, and fuel in a changing environment, with innovative crop protection solutions that include biologicals, crop nutrition, and digital agriculture to address agricultural challenges economically.
- Forward-Looking Statements: The announcement includes caution regarding forward-looking statements, highlighting that future performance and market conditions may be influenced by various risks and uncertainties, advising investors to be cautious in relying on such statements.
See More
FMC Corporation Q1 Earnings Announcement Scheduled
- Earnings Release Date: FMC Corporation is set to announce its Q1 earnings on April 29th after market close, with consensus EPS estimate at -$0.38 and revenue forecast at $742.41 million, reflecting a 6.2% year-over-year decline, indicating challenges in the current economic environment.
- Historical Performance Review: Over the past two years, FMC has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating a degree of stability in financial performance, although recent estimate revisions indicate downward pressure.
- Estimate Revision Trends: In the last three months, there have been no upward revisions for EPS estimates and 11 downward revisions, while revenue estimates also saw no upward revisions and 7 downward adjustments, suggesting weakened market confidence in FMC's future performance, which may affect investor sentiment.
- Market Dynamics: Despite facing challenges, FMC's recent approval for the Isoflex herbicide active ingredient in the EU may support future product line expansion and enhance market competitiveness, showcasing its ongoing innovation capabilities in the agricultural chemicals sector.
See More
Old North State Fully Divests FMC Stake Amid Losses
- Complete Exit from FMC: Old North State Wealth Management sold its entire stake of 295,829 shares in FMC Corporation during Q1 2026, with an estimated transaction value of approximately $4.42 million, indicating a significant loss of confidence in FMC's future prospects.
- Significant Price Decline: As of April 16, 2026, FMC shares were priced at $17.58, reflecting a 50% drop over the past year, which starkly contrasts with the S&P 500's roughly 35% gain during the same period, highlighting the challenging market conditions faced by the company.
- Deteriorating Financials: FMC's annual revenue has declined by 18% to around $3.47 billion, resulting in a net loss of $2.24 billion primarily due to impairments and restructuring efforts, with management projecting further revenue declines for 2026 between $3.6 billion and $3.8 billion.
- Strategic Alternatives Considered: The company is exploring strategic alternatives, including a potential sale, while aiming to reduce $1 billion in debt through asset disposals, indicating proactive measures to improve its financial situation amidst ongoing challenges.
See More
